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Abstract
Studies using 24 h urine collections need to incorporate ways to validate the completeness of the urine samples. Models to predict urinary
creatinine excretion (UCE) have been developed for this purpose; however, information on their usefulness to identify incomplete urine
collections is limited. We aimed to develop a model for predicting UCE and to assess the performance of a creatinine index using para-
aminobenzoic acid (PABA) as a reference. Data were taken from the European Food Consumption Validation study comprising two non-
consecutive 24 h urine collections from 600 subjects in five European countries. Data from one collection were used to build a multiple
linear regression model to predict UCE, and data from the other collection were used for performance testing of a creatinine index-
based strategy to identify incomplete collections. Multiple linear regression (n 458) of UCE showed a significant positive association for
body weight (b ¼ 0·07), the interaction term sex £ weight (b ¼ 0·09, reference women) and protein intake (b ¼ 0·02). A significant nega-
tive association was found for age (b ¼ 20·09) and sex (b ¼ 23·14, reference women). An index of observed-to-predicted creatinine
resulted in a sensitivity to identify incomplete collections of 0·06 (95 % CI 0·01, 0·20) and 0·11 (95 % CI 0·03, 0·22) in men and women,
respectively. Specificity was 0·97 (95 % CI 0·97, 0·98) in men and 0·98 (95 % CI 0·98, 0·99) in women. The present study shows that
UCE can be predicted from weight, age and sex. However, the results revealed that a creatinine index based on these predictions is
not sufficiently sensitive to exclude incomplete 24 h urine collections.
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When biomarkers from 24 h urine collections are used in
validation studies of dietary assessment methods or in clinical
investigations, it is clearly inappropriate to use incomplete
urine collections. Currently, two markers are available to
check for a complete urine collection; urinary creatinine
excretion (UCE) and para-aminobenzoic acid (PABA).
In the past decades, scientific disagreement has been
reported on the appropriateness of UCE to serve as a
marker for identifying incomplete urine collections(1–6). Fur-
thermore, different strategies for excluding urine samples
based on creatinine excretion have been published(3,7–10).
One strategy to exclude specimens is based on the ratio of
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observed over expected UCE (creatinine index)(10). Expected
UCE (mg/d) is derived from the observed weight of the
person and calculated as: body weight (kg) £ 24 (males) or
21 (females)(10). According to Joossens & Geboers(10), urine
collections with a creatinine index falling outside the range
of 0·6–1·4 should be discarded.
Because some investigators argued that creatinine excretion
is not a reliable marker to detect incomplete urine collections,
use of the exogenous marker PABA has been proposed(11).
As PABA is actively absorbed and rapidly and completely
excreted in urine, it is suitable to verify completeness of
urine collections based on the simple principle of an expected
minimal PABA recovery in sampled urine(12).
Currently, there are no recent data available on creatinine
excretion in a large European sample, or on its potential
value to serve as a marker for detection of incomplete urine
collections. Also, models to predict UCE have been published
before, although information on their performance to cor-
rectly identify incomplete urine samples is limited.
The objective of the present study is, first, to develop a
multiple linear regression model which is able to predict
UCE using readily available subject information and, secondly,
to investigate the suitability of UCE as a marker for identifying
incomplete 24 h urine collections using PABA as a reference.
Subjects and methods
Subjects
The study group comprised 600 healthy European adults (297
males and 303 females aged 45–65 years) participating in the
European Food Consumption Validation (EFCOVAL) study.
Data were collected in five European countries: Belgium, the
Czech Republic, France (Southern part), the Netherlands and
Norway. In all countries, a convenience sample was recruited
targeting equal numbers of men and women, and inclusion of
subjects from lower, intermediate and higher educational
levels. Exclusion criteria comprised the use of diuretics,
receiving diet therapy, simultaneous participation in another
study, pregnancy or lactation, having diabetes mellitus or
a kidney disease and donation of blood or plasma during
(or less than 4 weeks before) the study. In addition, because
of PABA administration during urine collections, use of
sulphonamide-based antibiotics or acetaminophen painkillers
(e.g. paracetamol) was not allowed and subjects hypersensi-
tive to sulphonamides or PABA were also excluded.
Urine collections
All subjects were carefully instructed to keep two 24 h urine
collections according to a standardised protocol. Days of
urine collection were randomly assigned, though with a time
interval of at least 4 weeks between the two collections. Sub-
jects were asked to urinate upon rising in the morning; this
micturition was completely discarded and the time was regis-
tered. This time was taken as the starting point of the 24 h
urine collection. Subsequently, all urine produced during the
next 24 h was collected up to, and including, the first voiding
of the following day. Subjects were provided a diary to register
the time of rising, observations (e.g. use of medication) and
possible deviations (e.g. missing urine) from the urine collec-
tion protocol. All urine voidings were stored in light-protected
receptacles containing boric acid (3 g/2 litre bottle) as a preser-
vative. In order to verify the completeness of urine collections,
an 80 mg PABA tablet (PABAcheck, Laboratories for Applied
Biology) was taken three times over the day, orally during a
meal. The underlying assumption to use PABA as a marker
for detection of incomplete urine collections is that it is
excreted almost quantitatively in 24 h. Hence, we expected
that approximately 240 mg of PABA would be present in
every 24 h urine sample(11). After 1 month, the same procedure
was repeated so that every subject yielded two 24 h urine col-
lections. Subjects’ body weight (kg) and height (cm) were
measured at the study centres before the first urine collection
(wearing light clothes and no shoes). This study was con-
ducted according to the guidelines laid down in the Declara-
tion of Helsinki and all procedures involving human subjects
were approved by the ethical committees in each country
involved in the data collection. Written informed consent
was obtained from all subjects.
Quantification of urinary analytes
At the study centre, urine samples were weighed and well
mixed before aliquoting into 10 ml cryo-storage tubes.
Aliquots were then frozen at 2208C until shipment on dry
ice to the central laboratory at Wageningen University (the
Netherlands), where they were kept at the same temperature.
On the day of chemical analysis, aliquots were rapidly thawed
at room temperature. PABA was measured using the colori-
metric diazocoupling method described by Bingham &
Cummings(11). The method is based on total quantification
of aromatic amines derived from PABA and its metabolites
after alkaline hydrolysis. Urinary creatinine concentrations
were measured at 520 nm on a Synchron LX20 (Beckman
Coulter) using a commercial kit which is a modification of
the kinetic Jaffe´ procedure.
Stability of PABA in urine was verified by storing urine
samples of three participants at four different temperatures
(220, 6, 20 and 308C) for 8 d. PABA concentrations were
measured at five moments (days 0, 1, 2, 4 and 7). No signifi-
cant changes in PABA concentrations were observed during
the storage period at each temperature. In addition, previous
studies have shown that in all but extreme cases (e.g. storage
at 558C for 30 d), urinary creatinine is virtually unaffected by
storage time and temperature in both acidified as in unpre-
served urine samples(13,14).
Dietary data
Two 24 h recalls were collected using EPIC-Soft software (ver-
sion 9.16; IARC). The structure and standardisation procedure
of EPIC-Soft have been described elsewhere(15,16). Briefly,
EPIC-Soft is an assisted dietary tool that follows standardised
steps when describing, quantifying, probing and calculating
food intakes across countries(15). Dietary recalls followed a
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randomised schedule, which included all days of the week.
Protein intake was calculated using mainly the country-specific
food composition tables and missing information from a
food was gathered from another similar food or another food
composition tables. The protein coverage of national food
composition tables was 100 % for all foods reported.
Statistical analysis
A stepwise regression approach was used for developing and
validating a model for creatinine prediction. Data from the
second urine collection were used for model development,
and data from the first collection for model validation. The
first collection was chosen to validate the model because
this corresponds with data that are available if only one
urine collection would be performed. When the first urine
collection was used for model development, the results did
not differ significantly from the present ones.
First, multiple regression with UCE from the second
urine collection as dependent variable was performed. The
independent variables – age, sex, weight, height and an
interaction term sex £ weight – were entered in the model.
The interaction term was included because regression of
weight to UCE showed different slopes for both sexes.
Because protein-rich foods are able to influence UCE(17)
(arginine and glycine are amino acid precursors of creatinine,
and creatine is present in meat), mean protein intake derived
from the dietary intake data was also included as an explana-
tory variable. Only cases with complete urine collections
according to PABA recovery $ 85 % were used to develop a
model for predicting UCE. Cook’s distance and studentised
residuals were used to analyse residuals and to assess the
influence of outliers.
Second, the predictive ability of the model was evaluated.
Therefore, expected UCE was calculated for every participant
by using the regression equation of the model. The standard
error of the model was used to calculate 95 % CI around
predicted UCE. Next, the percentage of actual values for
UCE from collection 1 that were located within 95 % CI of
the predicted UCE was calculated.
Subsequently, the suitability of creatinine to serve as a
marker for identifying incomplete urine collections was inves-
tigated. Therefore, the performance of the ratio observed over
expected UCE was tested using PABA recovery as a reference.
The two ratios were calculated and compared. For the first
ratio, expected UCE was body weight-derived as proposed
by Joossens & Geboers(10). In the second ratio, expected
UCE was derived from the regression equation of the final
regression model. For both ratios, collections were classified
as incomplete using the cut-off by Murakami et al.(3) (creati-
nine index , 0·7 ¼ incomplete collection). Finally, sensitivity
was calculated as the proportion of participants with incom-
plete urine collections correctly classified, and specificity as
the proportion of participants with complete urine collections
correctly classified. For comparison of groups, the like-
lihood ratio of a positive test was also calculated (sensitivity/
(1 2 specificity)). For all figures, 95 % CI are reported.
Results
Participant characteristics are listed in Table 1. The mean age
of the participants was 55·2 (SD 5·7) years for men and 54·7 (SD
5·8) years for women. Mean BMI was, respectively, 26·7 (SD
3·5) and 24·7 (SD 4·1) kg/m2 for men and women. In men,
34 % of the participants had a BMI below 25 kg/m2, and in
women this was 61 %. All participants (n 600) collected their
urine the first time; but two participants failed to perform
the second collection. Diaries were analysed to inventory
deviations from the urine collection protocol. Overall, four
and ten participants reported not having taken all three
PABA tablets during collections 1 and 2, respectively. Prohib-
ited medication intake during urine collections 1 and 2 was
reported by two and six participants, respectively. During col-
lections 1 and 2, respectively, fifty-four and fifty-eight partici-
pants reported that not all urine could be collected. Finally, in
three urine specimens (two from collection 1; one from collec-
tion 2), creatinine could not be determined. Taking all devi-
ations from the first and second urine collections and
analysis protocol into account, respectively, 541 (90·2 %) and
528 (88·3 %) specimens were available for data analysis.
Mean self-reported collection time was close to 24 h (23·90 h
for men during both collections, 23·9 and 24 h during the
first and second collections for women; Table 2). PABA recov-
ery was proximate to 100 % (range of means: 98·0 (SD 15·6) to
102·2 (SD 11·7) %), and 86·2 % (women during the second
urine collection) to 93·5 % (men during the first urine collec-
tion) of PABA recoveries had values equal to or above 85 %.
Mean weight-adjusted creatinine excretion was 21 mg/kg in
men and 17 mg/kg in women.
For the prediction of UCE, the multiple regression model
showed a significant positive association for the interaction
term sex £ weight (b ¼ 0·09, P , 0·001), weight (b ¼ 0·07,
P , 0·001) and protein intake (b ¼ 0·02, P , 0·001). A signifi-
cant negative association was found for age (b ¼ 20·09,
P , 0·001) and sex (b ¼ 23·14, P ¼ 0·006; Table 3). The vari-
ables in the model explained more than three-quarters
(adjusted R 2 0·76) of the variance in predicted UCE with a
Table 1. Characteristics of participants
(Mean values and standard deviations; percentages and
number of participants)
Men (n 297) Women (n 303)
Mean SD Mean SD
Age (years) 55·2 5·7 54·7 5·8
Weight (kg) 83·6 12·5 67·0 11·9
Height (cm) 177 7·5 165 7·4
BMI (kg/m2) 26·7 3·5 24·7 4·1
n % n %
BMI category (kg/m2)
, 25 100 34 185 61
25–29·9 151 51 89 29
$ 30 46 15 29 10
Educational level
Low 50 17 66 22
Intermediate 73 24 96 32
High 174 59 141 47
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correlation coefficient of 0·87. The standard error of the esti-
mate was 1·884 mmol/d. UCE values from seven participants
were identified as outliers and excluded before model devel-
opment, and from one participant no dietary intake data were
available (n 458).
When UCE measurements from the first collection were
compared to the predicted UCE using the regression equation,
93·5 % of the measurements fell within the 95 % CI of the
prediction.
Sensitivity and specificity of UCE and the likelihood ratio of
a positive test for identification of incomplete urine collectors
are reported in Table 4 using different ratios. First, the per-
formance of the strategy proposed by Murakami et al.(3) is pre-
sented. When a cut-off of 0·7 was used for the creatinine
index, sensitivity and specificity was, respectively, 0·49 (95 %
CI 0·34, 0·63) and 0·88 (95 % CI 0·84, 0·89). For females, sen-
sitivity was higher (0·63) and specificity lower (0·81) com-
pared to the total group. In males, sensitivity was markedly
lower (0·33) and specificity slightly higher (0·94) compared
to total group figures. The likelihood of an incomplete urine
collection was increased 4-fold, given a positive test result
(5·8 and 3·4 for males and females, respectively). When the
estimated UCE was calculated using the regression equation
and the same cut-off for detection of incomplete urine collec-
tions was used, sensitivity was very low (0·08) and specificity
almost excellent (0·98). Explorations of other cut-offs
accompanied with their respective measures for sensitivity,
specificity and positive likelihood ratios are presented in
Table 5. Finally, Fig. 1 shows a scatter-plot from observations
for PABA recoveries and ratios of observed-to-predicted
creatinine. Both cut-offs for the detection of incomplete
urine collections by PABA and creatinine ratio are indicated
by a horizontal and vertical line, respectively. The large scatter
shows that shifting the cut-off of the ratio observed over
expected creatinine to the right (i.e. using a higher cut-off)
will lead to an important increase of false-positive results.
Discussion
In the present study, measures from duplicate 24 h urine
collections are used to develop a prediction model for estimat-
ing urinary creatinine excretion on one hand and to test the
performance of urinary creatinine to serve as an indicator
for detecting incomplete urine collections on the other. For
the latter, PABA is used as a reference and is assumed to
correctly identify incomplete urines. The model presented in
this paper is able to explain up to 76 % of the variance in urin-
ary creatinine excretion when using sex, age, weight and
sex £ weight as independent variables. Although 93·5 % of
the observed urinary creatinine values from urine collection
1 fell within 95 % CI of the model predictions from urine col-
lection 2, the sensitivity of the ratio of observed-to-predicted
creatinine was very low when using traditional cut-offs for
the creatinine index. Sensitivity improved after increasing
the cut-off (e.g. to 0·95); however, given the trade-off between
sensitivity and specificity, this also decreases specificity.
Table 2. Characteristics of urine collections*
(Mean values and standard deviations; percentages and number of participants)
Urine collection
First Second
Men (n 278) Women (n 263) Men (n 267) Women (n 261)
Mean SD Mean SD Mean SD Mean SD
Total urine volume (ml/d) 2114 849 2336 911 2105 817 2313 944
Reported collection time (h) 23·9 1·1 23·9 1·1 23·9 1·0 24·0 0·7
Urinary PABA (mg/d) 245·2 28·0 239·5 30·9 240·3 39·0 234·5 37·0
PABA recovery (%) 102·2 11·7 99·6 13·2 100·1 16·2 98·0 15·6
, 85 %
n 18 19 26 36
% 6·5 7·2 9·7 13·8
$ 85 %
n 260 244 241 225
% 93·5 92·8 90·3 86·2
Urinary creatinine (mmol/l) 8·6 3·6 5·0 2·5 8·5 3·6 5·0 2·3
Total urinary creatinine (mmol/d) 15·7 3·2 9·9 1·9 15·6 3·3 9·9 2·0
Urinary creatinine:body weight (mg/kg) 21·4 3·6 17·1 3·2 21·2 3·6 17·1 3·5
PABA, para-aminobenzoic acid.
* Only collections that fully complied with the protocol are presented (total nfirst 541, total nsecond 528).
Table 3. Model coefficients of multiple linear regression*
b
UCE (mmol/d)† b SE 95 % CI P
Constant 9·36 1·132 7·136, 11·585 ,0·001
Sex‡ 23·14 1·141 25·377, 20·892 0·006
Weight (kg) 0·07 0·011 0·048, 0·093 ,0·001
Sex £ weight 0·09 0·015 0·058, 0·118 ,0·001
Age (years) 20·09 0·015 20·123, 20·063 ,0·001
Protein (g/d) 0·02 0·003 0·009, 0·021 ,0·001
UCE, urinary creatinine excretion; SE, sensitivity.
* Model based on data from the second urine collection. Only collections that fully
complied with the protocol and para-aminobenzoic acid recoveries equal to or
above 85 % were included. Overall, seven cases were identified as outliers based
on studentised residuals and Cook’s distance and excluded from the model.
† Model summary: R 0·87, adjusted R 2 0·76, SE estimated 1·884 mmol/d, n 458.
‡ Sex ¼ 0 for females, 1 for males.
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In a study performed by Murakami et al.(3), the sensitivity
and specificity of different strategies using creatinine as an
indicator for identification of incomplete urine collections
against PABA were investigated. The strategy using a creati-
nine index with a cut-off of 0·7 was considered to be poten-
tially useful for identifying incomplete 24 h urine collections.
The sensitivity and specificity among 654 Japanese girls
(mean age 19·7 (SD 1·1) years) were, respectively, 0·47 and
0·99. In the present study, sensitivity and specificity in females
using the strategy by Murakami et al.(3) was 0·63 and 0·81,
respectively. The sample characteristics from this latter study
are different as compared to those from the present sample
in terms of age, ethnicity and educational diversity.
The sensitivity in men (0·33) was roughly half the sensiti-
vity in women (0·63) in the present study. A lower sensitivity
in men compared to women was also demonstrated in a
small-scale study (n 83), comprising data from six European
countries, performed by Knuiman et al.(2), where sensitivity
was 0·07 for men compared to 0·13 for women. It is note-
worthy to mention that in their study a different cut-off (i.e.
0·6) was used. When a cut-off of 0·6 was used on the present
data, sensitivity was 0·05 for men and 0·36 for women (data
not shown). Regardless of the cut-off or study sample, it is
clear that when exclusion of collections is based on UCE, a
large part of incomplete collections remains unidentified
because of low sensitivity, resulting in an underestimation of
urine-based analytes used during further analysis.
In this study, the fraction of incomplete collections was 6·5
and 9·7 % for the first and second collections in men, and 7·2
and 13·8 % in women, respectively. Earlier studies have
reported prevalences of incomplete collections similar to the
ones reported here(3,5,18,19). A possible explanation for the
Table 4. Number of participants with incomplete and complete 24 h urine collections by para-aminobenzoic acid (PABA) and two test strategies,
and sensitivity (SE), specificity (SP) and positive likelihood ratios (LRþ ) of both test strategies for identifying incomplete 24 h urine collections
(Number of participants and 95 % confidence intervals)
Completeness of 24 h urine collection by PABA
Incomplete Complete
Completeness of 24 h
urine collection by test
strategy
Completeness of 24 h
urine collection by test
strategy
Test strategy Incomplete Complete Incomplete Complete n SE 95 % CI SP 95 % CI LRþ 95 % CI
Murakami et al.(3)*
All 18 19 61 443 541 0·49 0·34, 0·63 0·88 0·87, 0·89 4·0 2·6, 5·7
Male 6 12 15 245 278 0·33 0·17, 0·53 0·94 0·93, 0·96 5·8 2·5, 11·9
Female 12 7 46 198 263 0·63 0·42, 0·80 0·81 0·80, 0·83 3·4 2·1, 4·6
Regression model†
All 3 34 11 493 541 0·08 0·03, 0·17 0·98 0·97, 0·99 3·7 1·1, 11·6
Male 1 17 7 253 278 0·06 0·01, 0·20 0·97 0·97, 0·98 2·1 0·3, 11·7
Female 2 17 4 240 263 0·11 0·03, 0·22 0·98 0·98, 0·99 6·4 1·4, 28·3
* Participants with a value for (urinary creatinine (mg/d)/(G £ body weight (kg)) of ,0·7 were identified as having incomplete urine collections. G ¼ 21 for females and 24 for males.
† Ratio of observed:expected urinary creatinine excretion. Expected urinary creatinine excretion was calculated as (9·36 2 3·14 £ sex þ 0·07 £ weight þ 0·09 £ sex £
weight 2 0·09 £ age þ 0·02 £ protein intake). Participants with a ratio ,0·7 were identified as having incomplete urine collections.
Table 5. Sensitivity (SE), specificity (SP) and positive likelihood ratios (LRþ) from a range of
cut-offs from observed to expected creatinine calculated by the regression model*
All Male Female
Cut-off SE SP LRþ SE SP LRþ SE SP LRþ
0·50 0·00 1·00 0·0 0·00 1·00 0·0 0·00 1·00 –
0·55 0·00 0·99 0·0 0·00 0·99 0·0 0·00 1·00 0·0
0·60 0·05 0·99 6·8 0·00 0·99 0·0 0·05 1·00 12·8
0·65 0·05 0·99 4·5 0·00 0·98 0·0 0·11 1·00 25·6
0·70 0·08 0·98 4·5 0·06 0·97 0·0 0·11 0·98 12·8
0·75 0·22 0·97 6·8 0·17 0·97 5·4 0·26 0·97 8·0
0·80 0·38 0·93 5·6 0·33 0·93 4·8 0·42 0·94 6·8
0·85 0·49 0·87 3·9 0·39 0·88 3·3 0·58 0·87 4·4
0·90 0·65 0·77 2·8 0·56 0·81 2·9 0·74 0·73 2·7
0·95 0·81 0·61 2·1 0·78 0·62 2·1 0·84 0·60 2·1
1·00 0·89 0·47 1·7 0·94 0·49 1·9 0·84 0·45 1·5
1·05 0·95 0·33 1·4 0·94 0·34 1·4 0·95 0·32 1·4
1·10 0·97 0·22 1·3 0·94 0·22 1·2 1·00 0·23 1·3
* Regression equation of the model: expected urinary creatinine excretion (mg/d) ¼ 9·36 2 3·14 £ sex þ 0·07 £
weight þ 0·09 £ sex £ weight 2 0·09 £ age þ 0·02 £ protein intake (sex: male ¼ 1, female ¼ 0; weight (kg);
age (years); protein intake (g/d)).
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higher prevalence of incomplete urines in the second collec-
tion might be that participants did not follow the instructions
as consequent as the first time. Also, the collection protocol
was not explained to participants for the second collection,
which might have decreased the attention or motivation of
participants to collect all urine. Therefore, repeating of instruc-
tions and stressing the necessity of complete urine collections
is advised when multiple collections are requested. Mean
PABA recoveries (ranging from 98·0 % in women to 102·2 %
in men) were close to 100 % and in agreement with those
from past observations in a European sample(2) and somewhat
lower than the one reported by Murakami et al.(3) in a Japa-
nese sample (103·8 % after adjustment for self-reported
missed urine and collection time). In the literature, models
to predict creatinine have been described before(20–23) and
reported correlations between observed and predicted UCE
range from 0·50 to 0·64(21–23). However, no reference
method was used to assess the performance of these
models. From the present study, it can be concluded that
when an internal standard like PABA is used to check for com-
pleteness of urine collections, sensitivity of urinary creatinine
to identify incomplete urine collections is very disappointing.
This is the case for both cut-offs based on simple calculations
as for more advanced predictions based on multiple
regression modelling. However, both the ratio of observed-
to-predicted creatinine as total UCE from incomplete collec-
tions are significantly lower than those from complete
collections (data not shown).
For model development, data from the second urine
collection were used. Subsequently, UCE from the first urine
collection was compared to predicted UCE using the equation
generated by the model. This way, both model development
sample and model validation sample were large, comprising
458 and 504 cases, respectively. As mentioned before, there
was only a difference in prevalence of incomplete collections
between the first and second urine collections. Because
incomplete urine collections were excluded during both
model development and validation, this difference was
removed, making both collections equal. Due to the fact that
between-person variance in UCE is higher than within-
person variance, the high number of participants in the pre-
sent study is a major strength (CVbetween: 19·1 % for males,
18·3 % for females; CVwithin: 9·1 % for males, 9·2 % for females,
in the present study). Also, body weight of participants
was accurately weighed instead of self-reported. In addition,
an internal standard (PABA) was used to identify incomplete
urine collections. Nevertheless, PABA has also some limi-
tations. First, over-collection of urine cannot be detected.
For instance, participants might collect the first urine voiding
instead of discarding it. This will dilute urine concentration
leading to underestimations of its constituents. Second,
impaired renal function leads to under-collection. Therefore,
kidney disease was an exclusion criterion for enrolment
in the study. Third, it has been suggested that late night
meals interfere with PABA-resorption due to decreasing
of metabolism and excretion of PABA(2). This problem
was overcome in the present study by asking participants to
take the PABA tablet before 19.00 hours. Fourth, when the
colorimetric method is used for PABA-analysis, aromatic
amines are also determined(24). Because these compounds
can originate from drugs like paracetamol and sulphonamide,
use of these drugs was prohibited during study participation.
Fifth, previous studies(10,11) have shown excretions of PABA
(15–24 mg) originating from foods; so determination of base-
line PABA excretion, at least in a subsample, is advised
because any natural presence of PABA can result in an under-
estimation of incomplete urine collections. Sixth, a major
drawback of PABA use is that intake can be refused or
forgotten by study participants. Also, it can be considered
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Fig. 1. Comparing para-aminobenzoic acid (PABA)-recovery and creatinine ratio cut-offs in their ability to identify incomplete urine collections in our sample of
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inappropriate because of unknown interferences with bio-
logical samples of interest (e.g. genetic studies).
No self-reported dietary assessment method is capable
of capturing all protein intakes. When comparing protein
intake to urinary nitrogen, the EFCOVAL study found an
underestimation of the EPIC-Soft guided 24 h recall varying
from 1·4 % up to 14·7 % in men and 1·8 % up to 12·2 % in
women after adjusting for age, BMI and educational level(25).
Because of the small influence of dietary protein intake on
UCE(17), and the fact that underestimation of protein intake
is not large, the anticipated consequences for the present
results are assumed to be limited.
Development of a model for the prediction of urinary
creatinine based on anthropometrics logically implies the
inclusion of participants expected to deliver complete urine
collections only. Application of this method while assessing
the performance of a test strategy, however, will yield a
lower prevalence of incomplete urine collections, thereby
potentially affecting sensitivity and specificity calculations.
Additional analyses of our data nevertheless demonstrated a
limited impact of including fifty-four participants reporting
incomplete urine collections during the first collection, as
only four of these also showed to be catalogued as such by
the reference method (data not shown).
Finally, adjustments for missed urine have been proposed
elsewhere(3), as have corrections for collections with PABA
recoveries below 85 %(26). Given that one of the objectives
of the present study was to report on performance of strat-
egies to deal with suspicious urine collections in terms of
completeness, it was chosen not to adjust nor correct data
and to keep them as straightforward as possible, so that
consequences for inferences could be minimised.
The present study has shown that UCE can be predicted
from readily available subject information like sex, weight and
age. For the first time, the performance of a prediction-based
creatinine index in terms of sensitivity and specificity was
assessed against a reference method. When such a creatinine
index is used to exclude incomplete urines, sensitivity analysis
showed that 94–89 % of incomplete 24 h urine collections
remain unidentified in males and females, respectively. Also,
in this European sample, sensitivity to identify incomplete
urine collections of a traditional creatinine index was only 0·33
(95 % CI 0·17, 0·53) and 0·66 (95 % CI 0·42, 0·80) in males and
females, respectively. Therefore, based on the present findings,
both the prediction-based as the traditional creatinine index
can be considered as an unreliable marker for detection of
incomplete urine collections when compared to PABA.
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